Inhaled furosemide in hospitalized infants with viral bronchiolitis: a randomized, double-blind, placebo-controlled pilot study
- PMID: 18214942
- DOI: 10.1002/ppul.20765
Inhaled furosemide in hospitalized infants with viral bronchiolitis: a randomized, double-blind, placebo-controlled pilot study
Abstract
Objective: To evaluate the short and long-term clinical effects and the treatment-feasibility of inhaled-furosemide (IF) as compared with placebo via hood in hospitalized infants with viral-bronchiolitis (VB).
Study-design: A randomized, double-blind, placebo-controlled pilot-study was performed in previously healthy infants (0-12 months). Enrolled infants were randomized to receive either IF (2 mg/kg), or placebo nebulized by hood three times daily throughout the hospitalization. Clinical assessment (respiratory distress assessment instrument [RDAI]) was performed before, 30 and 60 min after the 1st daily inhalation. The short-term effects were evaluated by the RDAI, respiratory assessment change score (RACS) and oxygen requirement and the long-term effects by time to be weaned off oxygen, time to full enteral feeding, length of stay, and "ready to discharge" time.
Results: Both groups (16 infants each) had comparable characteristics at study entry. Mean (+/-SD) age was 72 +/- 43 days, and 29/32 infants were RSV positive. Oxygen requirement (FiO(2)) decreased significantly at 30 min post-inhalation (30 +/- 9.2% to 26 +/- 7.1%, P < 0.05) only in the IF group. RACSs and long-term effects of both groups were comparable. Analysis of IF particles generated by the hood-nebulizer demonstrated that 36% and 49% of the particles were <3 and 5 microm, respectively. No side effects were observed during IF treatment.
Conclusion: Based on our pilot study, IF has no significant clinical effects in hospitalized infants with VB. IF via hood seems to be feasible and safe.
(c) 2008 Wiley-Liss, Inc.
Similar articles
-
Aerosol delivery in respiratory syncytial virus bronchiolitis: hood or face mask?J Pediatr. 2005 Nov;147(5):627-31. doi: 10.1016/j.jpeds.2005.05.035. J Pediatr. 2005. PMID: 16291353 Clinical Trial.
-
Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience.Isr Med Assoc J. 2006 Mar;8(3):169-73. Isr Med Assoc J. 2006. PMID: 16599051 Clinical Trial.
-
A randomized, controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis.J Pediatr. 2002 Dec;141(6):818-24. doi: 10.1067/mpd.2002.129844. J Pediatr. 2002. PMID: 12461499 Clinical Trial.
-
Nebulized furosemide for the management of dyspnea: does the evidence support its use?J Pain Symptom Manage. 2008 Oct;36(4):424-41. doi: 10.1016/j.jpainsymman.2007.10.017. Epub 2008 May 12. J Pain Symptom Manage. 2008. PMID: 18468839 Review.
-
Advances in the pharmacological management of breathlessness.Curr Opin Support Palliat Care. 2009 Jun;3(2):103-6. doi: 10.1097/SPC.0b013e32832b37fa. Curr Opin Support Palliat Care. 2009. PMID: 19333124 Review.
Cited by
-
Evaluating the Placebo Status of Nebulized Normal Saline in Patients With Acute Viral Bronchiolitis: A Systematic Review and Meta-analysis.JAMA Pediatr. 2020 Mar 1;174(3):250-259. doi: 10.1001/jamapediatrics.2019.5195. JAMA Pediatr. 2020. PMID: 31905239 Free PMC article.
-
Systematic review of instruments aimed at evaluating the severity of bronchiolitis.Paediatr Respir Rev. 2018 Jan;25:43-57. doi: 10.1016/j.prrv.2016.12.006. Epub 2017 Feb 15. Paediatr Respir Rev. 2018. PMID: 28258885 Free PMC article. Review.
-
Efficacies of different treatment strategies for infants hospitalized with acute bronchiolitis.Clin Exp Pediatr. 2024 Nov;67(11):608-618. doi: 10.3345/cep.2023.01676. Epub 2024 Oct 28. Clin Exp Pediatr. 2024. PMID: 39463338 Free PMC article.
-
Safety and efficacy of phenylephrine nasal drops in bronchiolitis.Iran J Pediatr. 2014 Oct;24(5):593-7. Epub 2014 Oct 5. Iran J Pediatr. 2014. PMID: 25793067 Free PMC article.
-
Clinical pharmacology of furosemide in neonates: a review.Pharmaceuticals (Basel). 2013 Sep 5;6(9):1094-129. doi: 10.3390/ph6091094. Pharmaceuticals (Basel). 2013. PMID: 24276421 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous